New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020Research in context

• Main Authors: Zheng Hui (Author), Wang Yu (Author), Wang Fuzhen (Author), Shen Liping (Author), Zhang Guomin (Author), Liu Jianhua (Author), Wang Feng (Author), Miao Ning (Author), Li Jian (Author), Ding Guowei (Author), Meng Tongtong (Author), Tang Lin (Author), Zhang Shuang (Author), Li Mingshuang (Author), Li Yuan (Author), Wang Xiaoqi (Author), Liu Qianqian (Author), Zhang Qian (Author), Wu Dan (Author), Yan Tingting (Author), Su Qiudong (Author), Wang Miao (Author), Li Li (Author), Hou Qian (Author), Li Yixing (Author), Liu Yi (Author), Ye Shaodong (Author), An Zhijie (Author), Lance E. Rodewald (Author), Jia Jidong (Author), Wang Huaqing (Author), Yu Wenzhou (Author), Liu Zhongfu (Author), Li Qun (Author), Feng Zijian (Author), Yin Zundong (Author)
• Format: Book
• Published: Elsevier, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Since 1992, when recombinant hepatitis B vaccine was introduced in China, government health officials have used nationally representative serological surveys to monitor progress in prevention and control of hepatitis B. In 2020, we conducted the fourth seroepidemiological survey...